Seeing Is Believing
Currently out of the existing stock ratings of Matthew Henriksson, 4 are a BUY (100%).
Analyst Matthew Henriksson works at CITI with a stock forecast success ratio of 75% fulfilled within 111 days on average.
Matthew Henriksson’s has documented 8 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GMED, Globus Medical at 05-Aug-2021.
Analyst best performing recommendations are on GMED (GLOBUS MEDICAL).
The best stock recommendation documented was for GMED (GLOBUS MEDICAL) at 2/18/2021. The price target of $77 was fulfilled within 127 days with a profit of $13.5 (21.26%) receiving and performance score of 1.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
60
$8.56 (16.64%)
1 months 7 days ago
7/9 (77.78%)
$8.35 (16.17%)
64
Hold
60
$8.56 (16.64%)
58
2 months 4 days ago
11/22 (50%)
$5 (9.09%)
378
Buy
64
$12.56 (24.42%)
61
2 months 4 days ago
5/7 (71.43%)
$9 (16.36%)
104
Buy
75
$23.56 (45.80%)
70
6 months 5 days ago
6/11 (54.55%)
$23.69 (46.17%)
208
Buy
86
$34.56 (67.19%)
77
6 months 13 days ago
14/19 (73.68%)
$32.8 (61.65%)
232
What Year was the first public recommendation made by Matthew Henriksson?